Skip to main content

Table 1 Base case parameters

From: A comparative cost-effectiveness analysis of mechanical and pharmacological VTE prophylaxis after lower limb arthroplasty in Australia

Parameter Value
Age 67.5 years [27]
Gender 40.5% [27]
Body mass index 31 kg/m2 [6]
History of VTE 7.7% [28]
Fraction THA 43.5% [8]
Fraction TKA 56.5% [9]
DVT incidence with LMWH 4.48% per 11.52 days [27]
PE incidence with LMWH 0.25% per 11.52 days [27]
Non-major bleed incidence with LMWH 9.9% per 12 days [28]
Major bleed incidence with LMWH 1.9% per 10 days [7]
  1. DVT deep vein thrombosis, LMWH low-molecular-weight heparin, PE pulmonary embolism, THA total hip arthroplasty, TKA total knee arthroplasty, VTE venous thromboembolism